Core Viewpoint - The article emphasizes the importance of standardized clinical trials in the medical aesthetics industry, highlighting the need for scientific design, regulatory compliance, and reliable data to ensure the clinical value of innovative products [2]. Group 1: Clinical Trial Quality Management - The "Good Clinical Practice (GCP)" provides a unified standard for the industry, addressing the increasing complexity and compliance requirements of clinical trials in the medical aesthetics field [2]. - A special forum on "Clinical Trial Quality Management" was established to analyze GCP core points and discuss the implementation and regulatory requirements of medical aesthetics-related trials, promoting high-quality development through multi-party collaboration [2]. Group 2: Forum Details - The second forum on medical aesthetics was successfully held, with the next forum scheduled for October 31 to November 2, 2025, at the Beijing Yinhai International Conference Center [4]. - The agenda for the "Clinical Trial Quality Management" forum includes various presentations from experts in the field, covering common issues in clinical trials, high-quality research design, collaboration for quality trials, and ethical review from a legal perspective [5]. Group 3: Participants - The forum is expected to attract a diverse group of participants, including senior lawyers, medical device and aesthetics company representatives, clinical doctors, researchers, investment institution representatives, regulatory experts, and industry observers [7].

Core Viewpoint - The article emphasizes the importance of standardized clinical trials in the medical aesthetics industry, highlighting the need for scientific design, regulatory compliance, and reliable data to ensure the clinical value of innovative products [2]. Group 1: Clinical Trial Quality Management - The "Good Clinical Practice (GCP)" provides a unified standard for the industry, addressing the increasing complexity and compliance requirements of clinical trials in the medical aesthetics field [2]. - A special forum on "Clinical Trial Quality Management" was established to analyze GCP core points and discuss the implementation and regulatory requirements of medical aesthetics-related trials [2]. Group 2: Forum Details - The second forum on the medical aesthetics industry was successfully held, with the next forum scheduled for October 31 to November 2, 2025, at the Beijing International Conference Center [4]. - The agenda for the Clinical Trial Quality Management forum includes various presentations from experts in the field, covering common issues in clinical trials, high-quality research design, collaboration for effective trials, and ethical review from a legal perspective [5]. Group 3: Participants - The forum is expected to attract a diverse group of participants, including senior lawyers, medical device and aesthetics company representatives, clinical doctors, researchers, investment institution representatives, and regulatory experts [7].